What Happened?
San Francisco, CA-based FibroGen Appointed Juan Graham as SVP, Chief Financial Officer
About the Company
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
About the Person
Juan Graham is SVP, Chief Financial Officer at FibroGen. Previously, Juan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile